Southwest Research Institute today broke ground on a new 21,000 square foot clinical supply facility to support government and industrial customers with integrated pharmaceutical and bioengineering research and development.
The new facility expands the footprint of our biotechnology laboratory and adds a dedicated biotechnology production suite with filtered air and low airborne particle counts. Our clinical supply facility will enable us to produce in vitro stem cells, certain types of vaccines, and small molecule therapeutics in a clean environment and at a scale that facilitates clinical trials for our clients. ”
Darrell Johnston, SwRI Director of Pharmaceutical and Biotechnology
SwRI plays a critical role in San Antonio’s highly connected biomedical ecosystem. As a pioneer in microencapsulation, bioengineering, and drug development, our institute can assist clients with significant R&D projects of any size, including small batches of rare disease therapeutics of less than 200 units. .
“We support the development of clinical supplies of both active pharmaceutical ingredients and formulated products needed for clinical research,” said Joe McDonough, Ph.D., vice president of chemistry and chemical engineering at SwRI. I am. “SwRI can guide our clients step-by-step from the initial concept stage through the drug discovery and FDA approval process. We leverage our extensive facilities to support our clients in the development of their clinical supplies.”
SwRI’s Rhodium™ docking platform accelerates the drug discovery process by screening millions of compounds to identify the best candidates. Developed more than a decade ago, rhodium was identified as a potential treatment during the COVID-19 pandemic. Researchers at the institute are currently using rhodium in drug discovery processes for other viruses and in DNA-targeted therapies to advance cancer research. Additionally, the bioreactors developed by SwRI can assist clients in developing novel biotherapeutics.
“The new pilot plant facility will provide three new Current Good Manufacturing Practice pilot plant suites and a quality control laboratory all under one roof, which will improve workplace and regulatory efficiencies and provide local, national and international “This will give us the space we need to serve more customers than ever before,” he said. Johnston.
Our laboratory adheres to current Good Manufacturing Practices in an FDA and DEA inspected facility.
sauce:
Southwest Research Institute
